Format

Send to

Choose Destination
Pediatr Pulmonol. 2020 Mar 18. doi: 10.1002/ppul.24734. [Epub ahead of print]

Insight into COVID-2019 for pediatricians.

Author information

1
Department of Pediatrics, Children's Hospital Affiliated of Zhengzhou University, Zhengzhou, China.
2
Department of Pediatrics, The First people's Hospital of Yunnan Province, Kunming, China.
3
Department of Pediatrics, Zhengzhou General Hospital, Zhengzhou, China.
4
National Engineering Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Abstract

Since December 2019, patients with unexplained pneumonia have been found in Wuhan City, Hubei Province, China. The pathogen in these cases is a new type of coronavirus. The World Health Organization confirmed this diagnosis and named the pathogen SARSCoV-2. The disease caused by SARSCoV-2 is called Corona Virus Disease (COVID-2019). The virus is highly infectious and pathogenic, causing human-to-human transmission. At present, SARSCoV-2 is still rampant in the world. Zhengzhou City in Henan Province serves as an example, 102 people have been confirmed to be infected with SARSCoV-2 (at 24:00 on February 5th, 2020), including three children, the youngest is 4 years old. From the perspective of clinical pediatricians as the first line fighting the epidemic, this paper will discuss the clinical characteristics, prevention and control measures, outcomes, diagnosis, and treatment of pediatric cases.

KEYWORDS:

COVID-2019; SARSCoV-2; pediatric infection

PMID:
32187887
DOI:
10.1002/ppul.24734

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center